Metformin preconditioning protects against myocardial stunning and preserves protein translation in a mouse model of cardiac arrest

Cody A. Rutledge , Claudia Lagranha , Takuto Chiba , Kevin Redding , Donna B. Stolz , Eric Goetzman , Sunder Sims-Lucas , Brett A. Kaufman
{"title":"Metformin preconditioning protects against myocardial stunning and preserves protein translation in a mouse model of cardiac arrest","authors":"Cody A. Rutledge ,&nbsp;Claudia Lagranha ,&nbsp;Takuto Chiba ,&nbsp;Kevin Redding ,&nbsp;Donna B. Stolz ,&nbsp;Eric Goetzman ,&nbsp;Sunder Sims-Lucas ,&nbsp;Brett A. Kaufman","doi":"10.1016/j.jmccpl.2023.100034","DOIUrl":null,"url":null,"abstract":"<div><p>Cardiac arrest (CA) causes high mortality due to multi-system organ damage attributable to ischemia-reperfusion injury. Recent work in our group found that among diabetic patients who experienced cardiac arrest, those taking metformin had less evidence of cardiac and renal damage after cardiac arrest when compared to those not taking metformin. Based on these observations, we hypothesized that metformin's protective effects in the heart were mediated by AMPK signaling, and that AMPK signaling could be targeted as a therapeutic strategy following resuscitation from CA. The current study investigates metformin interventions on cardiac and renal outcomes in a non-diabetic CA mouse model. We found that two weeks of metformin pretreatment protects against reduced ejection fraction and reduces kidney ischemia-reperfusion injury at 24 h post-arrest. This cardiac and renal protection depends on AMPK signaling, as demonstrated by outcomes in mice pretreated with the AMPK activator AICAR or metformin plus the AMPK inhibitor compound C.</p><p>At this 24-h time point, heart gene expression analysis showed that metformin pretreatment caused changes supporting autophagy, antioxidant response, and protein translation. Further investigation found associated improvements in mitochondrial structure and markers of autophagy. Notably, Western analysis indicated that protein synthesis was preserved in arrest hearts of animals pretreated with metformin. The AMPK activation-mediated preservation of protein synthesis was also observed in a hypoxia/reoxygenation cell culture model. Despite the positive impacts of pretreatment in vivo and in vitro, metformin did not preserve ejection fraction when deployed at resuscitation. Taken together, we propose that metformin's in vivo cardiac preservation occurs through AMPK activation, requires adaptation before arrest, and is associated with preserved protein translation.</p></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"4 ","pages":"Article 100034"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/92/nihms-1911045.PMC10327679.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular and cellular cardiology plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772976123000041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Cardiac arrest (CA) causes high mortality due to multi-system organ damage attributable to ischemia-reperfusion injury. Recent work in our group found that among diabetic patients who experienced cardiac arrest, those taking metformin had less evidence of cardiac and renal damage after cardiac arrest when compared to those not taking metformin. Based on these observations, we hypothesized that metformin's protective effects in the heart were mediated by AMPK signaling, and that AMPK signaling could be targeted as a therapeutic strategy following resuscitation from CA. The current study investigates metformin interventions on cardiac and renal outcomes in a non-diabetic CA mouse model. We found that two weeks of metformin pretreatment protects against reduced ejection fraction and reduces kidney ischemia-reperfusion injury at 24 h post-arrest. This cardiac and renal protection depends on AMPK signaling, as demonstrated by outcomes in mice pretreated with the AMPK activator AICAR or metformin plus the AMPK inhibitor compound C.

At this 24-h time point, heart gene expression analysis showed that metformin pretreatment caused changes supporting autophagy, antioxidant response, and protein translation. Further investigation found associated improvements in mitochondrial structure and markers of autophagy. Notably, Western analysis indicated that protein synthesis was preserved in arrest hearts of animals pretreated with metformin. The AMPK activation-mediated preservation of protein synthesis was also observed in a hypoxia/reoxygenation cell culture model. Despite the positive impacts of pretreatment in vivo and in vitro, metformin did not preserve ejection fraction when deployed at resuscitation. Taken together, we propose that metformin's in vivo cardiac preservation occurs through AMPK activation, requires adaptation before arrest, and is associated with preserved protein translation.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
二甲双胍预处理可以防止心肌休克,并保留心脏骤停小鼠模型中的蛋白质翻译
心脏骤停(CA)由于缺血再灌注损伤引起多系统器官损伤,死亡率高。我们小组最近的工作发现,在经历心脏骤停的糖尿病患者中,与未服用二甲双胍的患者相比,服用二甲双胍的患者在心脏骤停后心脏和肾脏损害的证据较少。基于这些观察结果,我们假设二甲双胍对心脏的保护作用是由AMPK信号介导的,AMPK信号可以作为CA复苏后的治疗策略。目前的研究调查了二甲双胍干预对非糖尿病CA小鼠模型心脏和肾脏结局的影响。我们发现两周的二甲双胍预处理可以防止射血分数降低,并减少骤停后24小时的肾缺血再灌注损伤。AMPK激活剂AICAR或二甲双胍加AMPK抑制剂化合物c预处理小鼠的结果表明,这种心脏和肾脏保护依赖于AMPK信号传导。在这个24小时的时间点上,心脏基因表达分析显示,二甲双胍预处理引起了支持自噬、抗氧化反应和蛋白质翻译的变化。进一步的研究发现线粒体结构和自噬标志物的相关改善。值得注意的是,Western分析表明,二甲双胍预处理动物的骤停心脏中保留了蛋白质合成。在缺氧/再氧化细胞培养模型中也观察到AMPK激活介导的蛋白质合成保存。尽管预处理在体内和体外都有积极作用,但在复苏时使用二甲双胍并不能保留射血分数。综上所述,我们提出二甲双胍的体内心脏保存是通过AMPK激活发生的,在停搏前需要适应,并且与保存的蛋白质翻译有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of molecular and cellular cardiology plus
Journal of molecular and cellular cardiology plus Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
审稿时长
31 days
期刊最新文献
Circulating autophagy regulator Rubicon is linked to increased myocardial infarction risk. Increased perivascular fibrosis and pro-fibrotic cellular transition in intramyocardial blood vessels in myocardial infarction patients. An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy. Modeling immune checkpoint inhibitor associated myocarditis in vitro and its therapeutic implications Dual calcium-voltage optical mapping of regional voltage and calcium signals in intact murine RyR2-R2474S hearts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1